European Journal of Inorganic Chemistry p. 1667 - 1672 (2017)
Update date:2022-08-16
Topics:
Hahn, Eva M.
Estrada-Ortiz, Natalia
Han, Jiaying
Ferreira, Vera F. C.
Kapp, Tobias G.
Correia, Jo?o D. G.
Casini, Angela
Kühn, Fritz E.
The lack of selectivity for cancer cells and the resulting negative impact on healthy tissue is a severe drawback of actual cancer chemotherapy. Tethering of cytotoxic drugs to targeting vectors such as peptides, which recognize receptors overexpressed on the surface of tumor cells, is one possible strategy to overcome such a problem. The pentapeptide cyc(RGDfK) targets the integrin receptor αvβ3, important for tumor growth and metastasis formation. In this work, two terpyridine-based RuII complexes were prepared and for the first time conjugated to cyc(RGDfK) through amide bond formation, which resulted in a monomeric and a dimeric bioconjugate. Both RuII complexes were found to bind strongly and selectively to integrin αvβ3, and the dimeric molecule displayed a 20-fold higher affinity to the receptor than the monomeric one. However, the cytotoxicity of the complexes and related bioconjugates against human A549 and SKOV-3 cell lines is still not sufficient for application as anticancer agents. Nevertheless, considering the high selectivity for integrin receptor αvβ3, the synthesis of Ru-based bioconjugates with cyc(RGDfK) paves a promising way towards the design of effective targeted anticancer agents.
View MoreShanghai Dano Pharmaceutical Co.,Ld.
Contact:+86-592-6266840
Address:Building 1 Room 512, 720 Cailun Rd, Zhangjiang High-Tech Park, Shanghai 201203, China
Shandong Bolode Bio-Technology Co., LTD
Contact:+86-0531-58966870
Address:136 Jingyi Road,Huaiyin District,Jinan,Shandong,China
Zhejiang Hoshine Silicon Industry Co., Ltd.
Contact:86-573-89179966
Address:Zhapu Town, Pinghu City, Zhejiang, China
Contact:86-571-61063068
Address:LINAN
website:http://www.chemdow.com
Contact:0086-10-82435335
Address:Room 401,Unit 3,4th Floor,Shangdijiayuan,Shangdi East Road, Haidian District,Beijing
Doi:10.1021/ja0684803
(2007)Doi:10.1016/j.tetlet.2006.10.109
(2006)Doi:10.1021/acs.jmedchem.5b02042
(2016)Doi:10.1021/jo00252a056
(1988)Doi:10.1246/cl.1999.1237
(1999)Doi:10.1007/s11164-016-2520-0
(2016)